Edity Therapeutics

Edity Therapeutics is a pioneering biotechnology research company focused on developing innovative delivery platforms. Edity Therapeutics is dedicated to advancing therapeutic solutions through the use of human immune cells to deliver therapeutic proteins directly to target cells. This groundbreaking technology enables precise modulation of intracellular pathways, addressing a range of diseases with proteins including gene editors, immune sensors, enzymes, and intrabodies.

Located in Rehovot, Israel, Edity Therapeutics is committed to transforming cell therapy and gene editing. The company operates with a focus on innovation and precision, striving to improve patient outcomes through advanced drug delivery methods. Edity Therapeutics continues to push the boundaries of biotechnology, making significant contributions to the fields of cancer research and gene therapy.

With its headquarters in Rehovot, Israel, Edity Therapeutics is strategically positioned to continue its groundbreaking work in biotechnology research. We invite the management team at Edity Therapeutics to enhance this profile further by creating a customized and exclusive company showcase and product listing on our platform.